December 24, 2008
Milbank Mills restricted to continue feed production
The US Food and Drug Administration (FDA) has prohibited Missouri-based Milbanks Mills from manufacturing, processing, or distributing medicated animal feed.
Milbank Mills and its officers Edward Milbank and Darrell Allen, face these restrictions until they comply with current Good Manufacturing Practice (cGMP) requirements for medicated animal feeds.
FDA said it had inspected Milbank Mills four times over the past five years, and found numerous deviations from the cGMP that resulted in voluntary recalls of medicated animal feeds.
FDA said the company continued to manufacture medicated animal feeds in violation of the Federal Food, Drug, and Cosmetic Act and its regulations, despite repeated warnings.
Among other cGMP violations, Milbank Mills repeatedly failed to store and handle drugs properly to maintain their effectiveness, did not maintain records of drug inventory and use, and did not adequately test its feed products to ensure that they contained the correct amounts of drugs. In addition, Milbank Mills did not accurately label its medicated feed products or provide adequate directions for their use.
Medicated animal feeds include specific types and amounts of drugs to prevent disease in food-producing animals, and failure to comply with cGMP requirements when manufacturing such feeds renders the product adulterated or illegal.
Under the consent decree, failure to comply with the terms could result in civil or criminal penalties. Consumers who may have purchased adulterated feed from Milbank Mills should contact the company directly.